Karol Bagh | IAS GS Foundation Course | 17 October | 8 AM. Call Us
This just in:

State PCS


Daily Updates


Governance

Waiving Intellectual Property Protection for Covid-19 Vaccines

  • 06 May 2021
  • 5 min read

Why in News

The United States has announced the support for waiving Intellectual Property (IP) protection for Covid-19 vaccines.

  • The decision is a breakthrough in India and South Africa's attempts to get World Trade Organisation (WTO) member countries to agree to such a waiver to fight the pandemic equitably.

Key Points

  • About:
    • The 1995 agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) requires ratifying countries to adopt a minimum standard of intellectual property rights to protect creators and promote innovation.
    • India and South Africa have proposed a waiver from the implementation and application of certain provisions of the TRIPS Agreement (waiving IP rights like patents, copyright, and trademarks) for prevention, containment or treatment of Covid-19.
    • If the waiver is granted, WTO member countries will not be under an obligation, for a temporary period, to either grant or enforce patents and other IP-related rights to Covid-19 drugs, vaccines, and other treatments.
      • This will immunise the measures adopted by countries to vaccinate their populations from claims of illegality under WTO law.
  • Need to Waive Patents on Covid Vaccines:
    • Monopoly of Drug Companies: At present, only drug companies which own patents are authorised to manufacture Covid vaccines.
      • A lifting of patents will allow the formula to be shared with other companies.
    • Vaccine Cost: Once the formula is shared, any company which possesses the required technology and infrastructure can produce vaccines.
      • This will lead to cheaper and more generic versions of Covid vaccines and will be a big step in overcoming vaccine shortage.
    • Inequitable Distribution of Vaccines: This has opened up a glaring gap between developing and wealthier countries now.
      • The countries having surplus doses of vaccines have already vaccinated a considerable percentage of their population and are returning to normalcy.
      • Whereas, the poorer nations continue to face shortages, have overburdened healthcare systems and hundreds dying daily.
    • Against the Interests of the World: The longer Covid circulates in developing nations, there is a greater chance of more vaccine-resistant, deadly mutations of the virus emerging.
  • Significance for India:
    • Help in Increasing Production: The bulk of the vaccine doses produced in India are taken up by foreign countries which could pay more for the doses.
      • This move can help scale up production to meet demand besides making the vaccines more affordable for everyone.
    • Preparation for the Third Wave: Indian authorities have stated that the third wave of the pandemic is inevitable.
      • Once the number of cases and deaths plateau, addressing shortages and making more affordable vaccines readily accessible could be the best way to prepare for the surge once again.
  • Counter Arguments:
    • Vaccine Quality and Safety may get Compromised: Lifting of patents would be a compromise on control of safety and quality standards for vaccine manufacturing.
    • Disincentive Pharmaceutical Companies: Lifting of patents would be a huge deterrent to investing heavily on vaccine development during pandemics in the future.
    • Can Lead to Confusion: Eliminating those protections would undermine the global response to the pandemic, including ongoing effort to tackle new variants.
      • It will create confusion that could potentially undermine public confidence in vaccine safety, and create a barrier to information sharing.

Way Forward

  • Waiving IP protections alone isn't enough to make vaccines available around the world. The countries must work with each other to expand manufacturing capabilities and support international vaccines.
  • It’s important for both Indian manufacturers and the government to address concerns of patent holders to make sure that India’s vaccination drive is not compromised in any way.

Source: IE

close
SMS Alerts
Share Page
images-2
images-2